{"id":"W3031465744","doi":"10.1200/jco.2020.38.15_suppl.5545","title":"Pembrolizumab (pembro) plus enzalutamide (enza) in patients (pts) with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort C efficacy, safety, and biomarker results.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Western University","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Cohort; Internal medicine; Abiraterone acetate; Biomarker; Oncology; Cancer; Urology; Androgen receptor; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007035824,0.0003967329,0.0005636737,0.0002386662,0.0002049117,0.0004516119,0.0003226324,0.0003086852,0.001399774],"category_scores_gemma":[0.0005204898,0.0002204922,0.0004456912,0.000373977,0.0001904008,0.0003821289,0.0002094073,0.0008133069,0.0003000551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008486301,"about_ca_system_score_gemma":0.001092572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002457997,"about_ca_topic_score_gemma":0.007509355,"domain_scores_codex":[0.9998277,0.00005801875,0.00001582075,0.00003082716,0.0000278179,0.00003974025],"domain_scores_gemma":[0.9997442,0.00002734853,0.00007246352,0.00001197322,0.0000123478,0.0001315509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5680257,0.02112773,0.09892004,0.001205874,0.002118425,0.0005973464,0.0004020213,0.003605483,0.05691515,0.0002900545,0.007078982,0.2397132],"study_design_scores_gemma":[0.1838563,0.4231483,0.365119,0.0001951037,0.002131846,0.001132234,0.0002105305,0.002570063,0.008100142,0.0002326263,0.01325287,0.00005090132],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951687,0.001959692,0.000152181,0.0001706091,0.00002275131,0.0005144271,0.0007668828,0.00002545119,0.001219163],"genre_scores_gemma":[0.9970636,0.0008421994,0.0003494685,0.0001847631,0.00002945586,0.0001676568,0.0008873793,0.000003173066,0.0004723194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002457997,"threshold_uncertainty_score":0.006157339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1066487543089281,"score_gpt":0.4288353122381401,"score_spread":0.3221865579292121,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}